The Defense Department’s reliance on Chinese supply chains for pharmaceuticals poses a severe national security risk, a Pentagon inspector general’s report warns.
The U.S. military’s ability to treat soldiers and personnel worldwide relies on products made and shipped in foreign countries. The Pentagon does not produce its own pharmaceuticals, so it relies on the American commercial sector to procure vital medicines for the armed forces. As the commercial sector increases its reliance on foreign countries the department follows suit, the report, which was released Wednesday, found.
